Evidence map›Paper›PMID 26843068›Full record

Observational studyBMC infectious diseases2016

Viral load monitoring and antiretroviral treatment outcomes in a pediatric HIV cohort in Ghana.

Omobolawa Kukoyi, Lorna Renner, Jonathan Powell, Oliver Barry, Meghan Prin, Jonas Kusah, Xiangyu Cong, Elijah Paintsil

Abstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Omobolawa KukoyiFrom Duke University School of Medicine, Durham, NC, USA. mkukoyi1@gmail.com.
Lorna RennerUniversity of Ghana School of Medicine and Dentistry, Accra, Ghana. lorna.renner@gmail.com.
Jonathan PowellWeill Cornell Medical College, New York, NY, USA. powell.jonathan@gmail.com.
Oliver BarryBoston Children's Hospital, Harvard Medical School, Boston, MA, USA. oliver.m.barry@gmail.com.
Meghan PrinColumbia University, New York, NY, USA. Meghan.prin@gmail.com.
Jonas KusahUniversity of Ghana School of Medicine and Dentistry, Accra, Ghana. jonaskusah@yahoo.co.uk.
Xiangyu CongYale Center for Analytical Sciences, Yale School of Medicine, New Haven, CT, USA. tcgggg@gmail.com.
Elijah PaintsilDepartments of Pediatrics, Pharmacology & Public Health, Yale University School of Medicine, 464 Congress Avenue, New Haven, CT, 06520, USA. elijah.paintsil@yale.edu.

Funding

A bioecological pediatric HIV disclosure intervention in Ghana - "SANKOFA"R01HD074253 · NICHD · YALE UNIVERSITY · PI PAINTSIL, ELIJAH, REYNOLDS, NANCY R · 2012 to 2016
$1.9M
NICHD NIH HHS R01 HD074253NICHD NIH HHS R01HD074253
6 · The paper itself

Abstract

backgroundHIV-infected children in sub-Saharan Africa may be at a high risk of staying on a failing first-line regimen and developing drug-resistance HIV variants due to lack of routine viral load monitoring. We investigated whether cumulative viral load, measured as viremia copy-years (VCY) could predict morbidity in a setting where viral load is not routinely monitored.

methodsThis was a single-center prospective observational longitudinal study of HIV-infected children initiating antiretroviral therapy (ART) at the Pediatric HIV/AIDS Care program at Korle-Bu Teaching Hospital in Accra, Ghana. The main outcome was morbidity measured as frequency of hospitalizations, opportunistic infections, and outpatient sick visits. The main explanatory variable was viral load measured as VCY.

resultsThe study included 140 children who initiated ART between September 2009 and May 2013 and had at least 2 viral load measurements. There were 184 hospitalizations, with pneumonia being the most common cause (22.8 %). A total of 102 opportunistic infections was documented, with tuberculosis being the most common opportunistic infection (68 %). A total of 823 outpatient sick visits was documented, with upper respiratory infections (14.2 %) being the most common cause. Forty-four percent of our study participants had >4 log10 VCY. Children in this sub-cohort had a higher frequency of sick visits compared with those with <4 log10 VCY (p = 0.03). Only 6.5 % of children with >4 log10 VCY had been identified as treatment failure using WHO clinical and immunological treatment failure criteria.

conclusionsHigh level of cumulative viral load may translate to virological failure and subsequent increased all-cause morbidity. Our finding of potential utility of VCY in pediatrics warrants further investigations. VCY may be a good alternate to routine viral load measurement as its determination may be less frequent and could be personalized to save cost.

Indexed as

AdolescentAnti-Retroviral AgentsChildChild, PreschoolFemaleGhanaHIV InfectionsHospitalizationHumansLongitudinal StudiesMaleMorbidityOpportunistic InfectionsPediatricsProspective StudiesTreatment OutcomeAnti-Retroviral Agents

Identifiers

PMID26843068
PMCPMC4738803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.